Cited by 782Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentHormonal and reproductive studies

Prospective Study of Sex Hormone Levels and Risk of Prostate Cancer

Gann, P. H., Hennekens, C. H., Ma, J., Longcope, C., Stampfer, M. J.·1996·JNCI Journal of the National Cancer Institute

Abstract

Background Sex steroids, particularly androgens, have been implicated in the pathogenesis of prostate cancer. Data from previous studies comparing circulating hormone levels in men with and without prostate cancer are difficult to interpret, since the studies were limited in size, hormone levels were analyzed in blood drawn after the diagnosis of cancer, nonrepresentative control subjects were used, and hormone and hormone-binding protein levels were not simultaneously adjusted. Purpose We conducted a prospective, nested case-control study to investigate whether plasma hormone and sex hormone-binding globulin (SHBG) levels in healthy men were related to the subsequent development of prostate cancer. Methods Among participants in the Physicians' Health Study who provided plasma samples in 1982, we identified 222 men who developed prostate cancer by March 1992. Three hundred ninety control subjects, matched to the case patients on the bases of age, smoking status, and length of follow-up, were also identified. Immunoassays were used to measure the levels of total testosterone, dihydrotestosterone (DHT), 3 alpha-androstanediol glucuronide (AAG), estradiol, SHBG, and prolactin in the stored (at -82 degrees C) plasma samples. Correlations between individual hormone levels and between hormone levels and SHBG in the plasma of control subjects were assessed by use of Spearman correlation coefficients (r). Odds ratios (ORs) and 95% confidence intervals (CIs) specifying the prostate ca…

Integrity signals

Registry

Crossref · 10.1093/jnci/88.16.1118

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cited by

Sorted by citations

Authors
Gann, P. H., Hennekens, C. H., Ma, J., Longcope, C., & Stampfer, M. J.
Affiliations
  • Northwestern University (US)
  • Brigham and Women's Hospital (US)
  • University of Massachusetts Chan Medical School (US)
  • Harvard University (US)
Corresponding author
Gann, P. H.
Venue
JNCI Journal of the National Cancer Institute
Published
1996-08-21
Volume
88
Issue
16
Pages
1118-1126
ISSN
  • 0027-8874 (ISSN-L)
  • 1460-2105
OpenAlex
W2116544030
Cited by
782
References
0
Citations by year
2026: 1 · 2025: 12 · 2024: 9 · 2023: 15 · 2022: 15 · 2021: 9 · 2020: 12 · 2019: 14 · 2018: 12 · 2017: 19 · 2016: 25 · 2015: 20 · 2014: 26 · 2013: 34 · 2012: 39
FWCI
24.33
Type
journal article
Language
en
Open access
closed
Locations
  • JNCI Journal of the National Cancer Institute (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Heart, Lung, and Blood Institute (HL-34595, HL 26490, R01HL034595)
  • National Cancer Institute (CA 34944)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Prostate Cancer Treatment and Research
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Prostate Cancer Diagnosis and Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Keywords
prostate cancer, sex hormones, testosterone, sex hormone-binding globulin, dihydrotestosterone, estradiol, prolactin, androgens, hormone levels, cancer risk, Physicians' Health Study, hormone binding proteins, hormone crosstalk, healthy men, hormone replacement therapy
MeSH terms
Adult, Aged, Aged, 80 and over, Estradiol, Humans, Male, Middle Aged, Prolactin, Prospective Studies, Prostatic Neoplasms, Risk, Sex Hormone-Binding Globulin, Gonadal Steroid Hormones, Dihydrotestosterone, Testosterone, Androstane-3,17-diol, Odds Ratio, Case-Control Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review